- Home
- MCRB vs TELO Comparison
MCRB vs TELO Comparison
Compare MCRB & TELO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MCRB
- TELO
- Stock Information
- Founded
- MCRB 2010
- TELO 2021
- Country
- MCRB United States
- TELO United States
- Employees
- MCRB N/A
- TELO N/A
- Industry
- MCRB Biotechnology: Pharmaceutical Preparations
- TELO
- Sector
- MCRB Health Care
- TELO
- Exchange
- MCRB Nasdaq
- TELO NYSE
- Market Cap
- MCRB 142.0M
- TELO 155.2M
- IPO Year
- MCRB 2015
- TELO 2024
- Fundamental
- Price
- MCRB $0.95
- TELO $5.15
- Analyst Decision
- MCRB Buy
- TELO
- Analyst Count
- MCRB 4
- TELO 0
- Target Price
- MCRB $4.17
- TELO N/A
- AVG Volume (30 Days)
- MCRB 3.0M
- TELO 135.3K
- Earning Date
- MCRB 10-31-2024
- TELO 08-13-2024
- Dividend Yield
- MCRB N/A
- TELO N/A
- EPS Growth
- MCRB N/A
- TELO N/A
- EPS
- MCRB N/A
- TELO N/A
- Revenue
- MCRB $374,000.00
- TELO N/A
- Revenue This Year
- MCRB N/A
- TELO N/A
- Revenue Next Year
- MCRB N/A
- TELO N/A
- P/E Ratio
- MCRB N/A
- TELO N/A
- Revenue Growth
- MCRB N/A
- TELO N/A
- 52 Week Low
- MCRB $0.54
- TELO $3.11
- 52 Week High
- MCRB $3.28
- TELO $20.72
- Technical
- Relative Strength Index (RSI)
- MCRB 53.10
- TELO N/A
- Support Level
- MCRB $0.77
- TELO N/A
- Resistance Level
- MCRB $0.87
- TELO N/A
- Average True Range (ATR)
- MCRB 0.10
- TELO 0.00
- MACD
- MCRB 0.01
- TELO 0.00
- Stochastic Oscillator
- MCRB 33.44
- TELO 0.00
About MCRB Seres Therapeutics Inc.
Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.
About TELO TELOMIR PHARMACEUTICALS INC
Telomir Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical company focused on the development and commercialization of TELOMIR-1, a novel small molecule being developed to function as an oral in situ therapeutic treatment for human stem cells.